LSK Global Pharma Services Co., Ltd. (LSK Global PS) is a leading Contract Research Organization (CRO) in Korea and is making its endless effort to contribute to the expansion of Korean pharmaceutical industry into the global market.
Since March 2000, when LSK Global PS kicked off its business, LSK Global PS has established its position as a one-stop, full-service CRO encompassing all of the major areas of clinical research, i.e. registration trials from phase I to III, investigator-sponsored clinical studies, post-registration studies such as phase IV studies, PMS studies, observational studies, etc., and consulting services for new drug development. As of Dec 2018, we have conducted about 1027 clinical studies so far, including about 641 registration trials and about 126 global clinical studies. LSK has been ISO 9001:2015 certified for overall clinical research services.